Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Cambridge Cognition execs invest after solid update

Fri, 22nd Jul 2022 14:04

(Sharecast News) - Cambridge Cognition was among a relatively thin list of director deals on Friday afternoon, after two of its executives made share purchases.

The AIM-traded firm said chief executive officer Dr Matthew Stork bought 22,950 shares for 113p each, spending a total of £25,933.50.

Chief financial officer Stephen Symonds, meanwhile, also bought 22,950 shares for 113p apiece.

Following the transactions, Cambridge Cognition said Dr Stork held 147,950 shares, or 0.47% of its issued capital, while Symonds held 22,950 shares, or 0.07%.

Both purchases were made on the London Stock Exchange on Thursday, when the company reported strong trading in an interim update.

Reporting by Josh White at Sharecast.com.

Top Director Buys

Cambridge Cognition Holdings (COG)

Director name: Stork,Matthew

Amount purchased: 22,950 @ 113.00p

Value: £25,933.50

India Capital Growth Fund Ltd. (IGC)

Director name: Timberlake,Nick

Amount purchased: 20,000 @ 105.85p

Value: £21,170.30

Ocado Group (OCDO)

Director name: Abrams,Neill

Amount purchased: 20 @ 770.00p

Value: £154.00

Ocado Group (OCDO)

Director name: Daintith,Stephen

Amount purchased: 20 @ 770.00p

Value: £154.00

Ocado Group (OCDO)

Director name: Richardson,Mark

Amount purchased: 20 @ 770.00p

Value: £154.00

Ocado Group (OCDO)

Director name: Jensen,Luke

Amount purchased: 20 @ 770.00p

Value: £154.00

Ocado Group (OCDO)

Director name: Steiner,Tim

Amount purchased: 20 @ 770.00p

Value: £154.00

Paypoint (PAY)

Director name: Wiles ,Nick

Amount purchased: 21 @ 597.90p

Value: £125.56

Paypoint (PAY)

Director name: Dale,Alan

Amount purchased: 21 @ 597.90p

Value: £125.56

Top Director Sells

Tristel (TSTL)

Director name: Swinney,Paul Christopher

Amount sold: 300,000 @ 333.00p

Value: £998,999.98

Dwf Group (DWF)

Director name: Stefani,Chris

Amount sold: 107,501 @ 95.80p

Value: £102,985.96

More News
28 Mar 2022 10:02

AIM WINNERS & LOSERS: Brighton Pier profit surges on strong summer

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
27 Mar 2022 10:38

Sunday share tips: Cambridge Cognition Holdings, FRP

(Sharecast News) - The Sunday Times's Lucy Tobin tipped shares of neuroscience outfit Cambridge Cognition Holdings to readers.

Read more
2 Feb 2022 12:40

Cambridge Cognition awarded contracts worth £2.1m

(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts worth £2.1m, it announced on Wednesday, to provide cognitive assessments, electronic diaries, and third-party hardware for two clinical trials in neurodegenerative disease.

Read more
2 Feb 2022 10:45

Cambridge Cognition jumps on GBP2.1 million clinical trial contract

Cambridge Cognition jumps on GBP2.1 million clinical trial contract

Read more
2 Feb 2022 10:32

AIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash

AIM WINNERS & LOSERS: AFC gets Extreme E boost; Chamberlin raises cash

Read more
27 Jan 2022 17:49

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust

TRADING UPDATES: Petropavlovsk expects lower output; Keywords robust

Read more
10 Jan 2022 12:44

Cambridge Cognition wins contracts for two clinical trials

(Sharecast News) - Brain health technology company Cambridge Cognition has been awarded contracts for two clinical trials by an unnamed "top 20" pharmaceutical company, it announced on Monday, to assess the pro-cognitive effects of a new drug in schizophrenia.

Read more
10 Jan 2022 12:19

Cambridge Cognition wins assessment contracts for schizophrenia drug

Cambridge Cognition wins assessment contracts for schizophrenia drug

Read more
16 Dec 2021 21:55

IN BRIEF: Cambridge Cognition wins second GBP500,000 contract

IN BRIEF: Cambridge Cognition wins second GBP500,000 contract

Read more
10 Dec 2021 15:03

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

TRADING UPDATES: Omega disputes repayment; BWA applies for licenses

Read more
2 Nov 2021 15:01

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

EXECUTIVE CHANGES: CFOs drop like flies; ex-IG CEO to chair Scotgold

Read more
26 Oct 2021 17:39

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

TRADING UPDATES: East Star makes buy; Kromek wins USD17 million deal

Read more
26 Oct 2021 09:11

Cambridge Cognition secures contract for 'sizeable' schizophrenia trial

(Sharecast News) - Digital brain health technology company Cambridge Cognition has secured a contract for a further sizeable schizophrenia trial with an existing customer, it announced on Tuesday.

Read more
21 Sep 2021 11:54

TRADING UPDATES: Cambridge Cognition in profit; PensionBee loss widens

TRADING UPDATES: Cambridge Cognition in profit; PensionBee loss widens

Read more
14 Sep 2021 16:11

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.